Premature or early bilateral oophorectomy: a 2021 update

References

• Utian WH. Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause. 2001;8:398–401.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 2011;1379:188–98.
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion No. 774: Opportunistic salpingectomy as a strategy for epithelial ovarian cancer prevention. Obstet Gynecol. 2019;133:e279–e284.
   PubMed Web of Science ®Google Scholar
• Nezhat C, Vang N, Tanaka PP, et al. Optimal management of endometriosis and pain. Obstet Gynecol. 2019;134:834–839.
   PubMed Web of Science ®Google Scholar
• van Lieshout LAM, Steenbeek MP, De Hullu JA, et al. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone. Cochrane Database Syst Rev. 2019;8:CD012858.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Missmer SA, Rocca WA. Moving beyond reflexive and prophylactic gynecologic surgery. Mayo Clin Proc. 2021;96:291–294.
   PubMed Web of Science ®Google Scholar
• The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24:728–753.
   PubMed Web of Science ®Google Scholar
• Kingsberg SA, Larkin LC, Liu JH. Clinical effects of early or surgical menopause. Obstet Gynecol. 2020;135:853–868.
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–226.
   PubMed Web of Science ®Google Scholar
• Olive DL. Dogma, skepsis, and the analytic method: the role of prophylactic oophorectomy at the time of hysterectomy. Obstet Gynecol. 2005;106:214–215.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, de Andrade M, et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7:821–828.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Gazzuola-Rocca L, Smith CY, et al. Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study. Mayo Clin Proc. 2016;91:1577–1589.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Gazzuola Rocca L, Smith CY, et al. Bilateral oophorectomy and accelerated aging: cause or effect? J Gerontol A Biol Sci Med Sci. 2017;72:1213–1217.
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses’ Health Study. Obstet Gynecol. 2009;113:1027–1037.
   PubMed Web of Science ®Google Scholar
• Parker WH, Feskanich D, Broder MS, et al. Long-term mortality associated with oophorectomy compared with ovarian conservation in the Nurses’ Health Study. Obstet Gynecol. 2013;121:709–716.
   PubMed Web of Science ®Google Scholar
• Mytton J, Evison F, Chilton PJ, et al. Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage. BMJ. 2017;356:j372.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Gazzuola Rocca L, Smith CY, et al. Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA). BMJ Open. 2017;7:e018861.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Gazzuola Rocca L, Smith CY, et al. Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: a population-based case-control study. Maturitas. 2018;117:64–77.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology. 2009;33:32–40.
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16:15–23.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074–1083.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008;70:200–209.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Grossardt BR, Geda YE, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause. 2008;15:1050–1059.
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Grossardt BR, Maki PM, et al. Risk of glaucoma after early bilateral oophorectomy. Menopause. 2014;21:391–398.
   PubMed Web of Science ®Google Scholar
• Kattah AG, Smith CY, Gazzuola Rocca L, et al. CKD in patients with bilateral oophorectomy. CJASN. 2018;13:1649–1658.
   PubMed Web of Science ®Google Scholar
• Huo N, Smith CY, Gazzuola Rocca L, et al. Association of premenopausal bilateral oophorectomy with restless legs syndrome. JAMA Netw Open. 2021;4:e2036058.
   PubMed Web of Science ®Google Scholar
• Zeydan B, Tosakulwong N, Schwarz CG, et al. Association of bilateral salpingo-oophorectomy before menopause onset with medial temporal lobe neurodegeneration. JAMA Neurol. 2019;76:95–100.
   PubMed Web of Science ®Google Scholar
• Levine ME, Lu AT, Chen BH, et al. Menopause accelerates biological aging. Proc Natl Acad Sci USA. 2016;113:9327–9332.
   PubMed Web of Science ®Google Scholar
• Rocca WA, Gazzuola Rocca L, Smith CY, et al. Loss of ovarian hormones and accelerated somatic and mental aging. Physiology (Bethesda). 2018;33:374–383.
   PubMed Web of Science ®Google Scholar
• Lu S, Xu F, Hu W, et al. SCD1 methylation in subcutaneous adipose tissue associated with menopausal age. Climacteric. 2019;22:395–402.
   PubMed Web of Science ®Google Scholar
• Rocca WA. Difficult decisions in women at high genetic risk for cancer: toward an individualized approach. Menopause. 2020;27:727–729.
   PubMed Web of Science ®Google Scholar
• Kaunitz AM, Faubion S. Surgical menopause: health implications and hormonal management. Menopause. 2020;28:1–3.
   PubMed Web of Science ®Google Scholar
• Moyer VA. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:271–281.
   PubMed Web of Science ®Google Scholar
• Sutcliffe S, Pharoah PD, Easton DF, et al. Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer. Int J Cancer. 2000;87:110–117.
   PubMed Web of Science ®Google Scholar
• Manchanda R, Legood R, Antoniou AC, et al. Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis. J Med Genet. 2016;53:591–599.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291:1701–1712.
   PubMed Web of Science ®Google Scholar
• Manson JE, Aragaki AK, Bassuk SS, et al. Menopausal estrogen-alone therapy and health outcomes in women with and without bilateral oophorectomy: a randomized trial. Ann Intern Med. 2019;171:406–414.
   PubMed Web of Science ®Google Scholar
• Donneyong MM, Chang TJ, Roth JA, et al. The Women’s Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groups. Menopause. 2020;27:632–639.
   PubMed Web of Science ®Google Scholar
• Chubaty A, Shandro MT, Schuurmans N, et al. Practice patterns with hormone therapy after surgical menopause. Maturitas. 2011;69:69–73.
   PubMed Web of Science ®Google Scholar
• Domchek S, Kaunitz AM. Use of systemic hormone therapy in BRCA mutation carriers. Menopause. 2016;23:1026–1027.
   PubMed Web of Science ®Google Scholar
• Faubion SS, Kuhle CL, Shuster LT, et al. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483–491.
   PubMed Web of Science ®Google Scholar
• Faubion SS, Files JA, Rocca WA. When lowest dose for shortest amount of time does not apply. J Womens Health (Larchmt). 2016;25:416–417.
   PubMed Web of Science ®Google Scholar
• Gazzuola Rocca L, Smith CY, Grossardt BR, et al. Adverse childhood or adult experiences and risk of bilateral oophorectomy: a population-based case-control study. BMJ Open. 2017;7:e016045.
   PubMedGoogle Scholar
• Gazzuola Rocca L, Smith CY, Stewart EA, et al. Adverse childhood experiences and adult abuse are predictors of hysterectomy and oophorectomy. Maturitas. 2017;106:95–96.
   PubMed Web of Science ®Google Scholar
• Gazzuola Rocca L, Smith CY, Bobo WV, et al. Mental health conditions diagnosed before bilateral oophorectomy: a population-based case-control study. Menopause. 2019;26:1395–1404.
   PubMed Web of Science ®Google Scholar